Our results indicated that EIF5A2 was an independent adverse prognostic marker of overall survival (OS), failure-free survival (FFS), and distant FFS (D-FFS) in NPC patients. The gene discussed is EIF5A2; the disease is nasopharyngeal carcinoma.